125 related articles for article (PubMed ID: 7784307)
1. Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen.
Cuzzolin L; Conforti A; Adami A; Lussignoli S; Menestrina F; Del Soldato P; Benoni G
Pharmacol Res; 1995 Jan; 31(1):61-5. PubMed ID: 7784307
[TBL] [Abstract][Full Text] [Related]
2. Nitronaproxen: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, NO-Naproxen.
Drugs R D; 2006; 7(4):262-6. PubMed ID: 16784252
[TBL] [Abstract][Full Text] [Related]
3. Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofenac.
Conforti A; Donini M; Brocco G; Del Soldato P; Benoni G; Cuzzolin L
Agents Actions; 1993 Nov; 40(3-4):176-80. PubMed ID: 8023740
[TBL] [Abstract][Full Text] [Related]
4. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
Wallace JL; Caliendo G; Santagada V; Cirino G
Br J Pharmacol; 2010 Mar; 159(6):1236-46. PubMed ID: 20128814
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems.
Conforti A; Bertani S; Lussignoli S; Grigolini L; Terzi M; Lora S; Caliceti P; Marsilio F; Veronese FM
J Pharm Pharmacol; 1996 May; 48(5):468-73. PubMed ID: 8799869
[TBL] [Abstract][Full Text] [Related]
6. Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats.
Cuzzolin L; Conforti A; Donini M; Adami A; Del Soldato P; Benoni G
Pharmacol Res; 1994; 29(1):89-97. PubMed ID: 8202446
[TBL] [Abstract][Full Text] [Related]
7. Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat.
Calhoun W; Gilman SC; Datko LJ; Copenhaver TW; Carlson RP
Agents Actions; 1992 May; 36(1-2):99-106. PubMed ID: 1414694
[TBL] [Abstract][Full Text] [Related]
8. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats.
Jarosz M; Szkaradek N; Marona H; Nowak G; Młyniec K; Librowski T
Inflammopharmacology; 2017 Dec; 25(6):653-663. PubMed ID: 28536986
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory activity of the isoquinoline alkaloid, tetrandrine, against established adjuvant arthritis in rats.
Whitehouse MW; Fairlie DP; Thong YH
Agents Actions; 1994 Oct; 42(3-4):123-7. PubMed ID: 7879697
[TBL] [Abstract][Full Text] [Related]
11. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.
Cicala C; Ianaro A; Fiorucci S; Calignano A; Bucci M; Gerli R; Santucci L; Wallace JL; Cirino G
Br J Pharmacol; 2000 Jul; 130(6):1399-405. PubMed ID: 10903982
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
13. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
Futaki N; Yoshikawa K; Hamasaka Y; Arai I; Higuchi S; Iizuka H; Otomo S
Gen Pharmacol; 1993 Jan; 24(1):105-10. PubMed ID: 8482483
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and analgesic profile of amidines of 3-amino-1,2,4-benzotriazine and 3-amino-1,2,4-benzotriazine-1-oxide.
Regan BA; Hanifin JW; Landes MJ; Osterberg AC; Patel GJ; Ridge DN; Sloboda AE; Lang SA
J Pharm Sci; 1980 Jul; 69(7):789-93. PubMed ID: 6967113
[TBL] [Abstract][Full Text] [Related]
15. Naproxcinod: AZD 3582, HCT 3012, naproxen nitroxybutylester, nitronaproxen, NO-naproxen.
Drugs R D; 2007; 8(4):255-8. PubMed ID: 17596112
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S
Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
19. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
Fomenko I; Sklyarov A; Bondarchuk T; Biletska L; Panasyuk N; Wallace JL
Stress; 2014 Dec; 17(6):528-37. PubMed ID: 25238023
[TBL] [Abstract][Full Text] [Related]
20. Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat.
Muscará MN; McKnight W; Del Soldato P; Wallace JL
Life Sci; 1998; 62(15):PL235-40. PubMed ID: 9566780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
